Lotus Bio-Technology Development Corp
OTC:LBTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Advance United Holdings Inc
CNSX:AUHI
|
CA |
|
Newborn Town Inc
HKEX:9911
|
CN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (31.9), the stock would be worth $-5.26 (52 719% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.1 | $0.01 |
0%
|
| Industry Average | 31.9 | $-5.26 |
-52 719%
|
| Country Average | 9.6 | $-1.58 |
-15 866%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| HK |
L
|
Lotus Bio-Technology Development Corp
OTC:LBTD
|
783 USD | -0.1 | -0.1 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
266.9B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 3 417.4 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
102.6B ZAR | 14.4 | 10.6 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.3B USD | -18 057 | 38 562.1 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
58.9B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
36.4B CHF | 0 | 0 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
39.2B USD | -4 663.1 | -3 510.2 | |
| US |
|
Coupang Inc
F:788
|
33B EUR | 33.8 | 183.4 | |
| US |
R
|
Reddit Inc
NYSE:RDDT
|
31.7B USD | 61 | 57.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 4.8 |
| Median | 9.6 |
| 70th Percentile | 14.9 |
| Max | 9 749.3 |
Other Multiples
Lotus Bio-Technology Development Corp
Glance View
Lotus Bio-Technology Development Corp. refines organic materials to produce natural consumer products. The firm focuses on specializing in the refining of organic materials and the production of natural consumer related products. The company is exploring opportunities in the organic growth and farming sector in China. The firm's operations are organizational matters, planning its Websites and developing its business plan. The firm is in start-up stage and has not generated any revenues.
